Clinical Trials Browser

Phase 2 × Recruiting × aumolertinib × Clear all

NCT06951464 2025-07-23

A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04423185 2025-02-11

PLATFORM Study of Precision Medicine for Rare Tumors

Phase 2 Recruiting

Rare Tumor

NCT06300424 2024-04-17

NEOVADE

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung